Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Steroid injection into neck muscle trigger points versus C2 dorsal root ganglion (nerve) block for chronic cervicogenic headache

Official title: Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Musculoskeletal Pain(CMP), Chronic Migraine and Cervicogenic Headache

Run by Beijing Tiantan Hospital · NCT07347730 · Data updated 2026-11-12

This trial will test whether steroid injections into neck myofascial trigger points work as well as C2 dorsal root ganglion (nerve) blocks to reduce pain in adults with chronic cervicogenic headache.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment1036 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 1, 2026
Study endsJune 1, 2027
Registry record updatedJanuary 16, 2026
Trial IDNCT07347730 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with a clinician-confirmed diagnosis of cervicogenic headache lasting at least 3 months and an NRS pain score of 3 or higher despite conservative medications are ideal candidates.

Probably not a fit

Patients with steroid allergy, active infection, severe organ dysfunction, pregnancy or breastfeeding, long-term opioid or steroid therapy, or other major exclusions are unlikely to benefit and are excluded from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, blinded-outcome, non-inferiority trial comparing two injection treatments for chronic cervicogenic headache. Enrolled adults are randomly assigned to receive either glucocorticoid injection at myofascial trigger points (MTrPs) or dorsal rami/C2 nerve blocks, with procedures performed at a single center. Patients will be followed for up to two years with regular assessments of pain intensity (NRS), attack frequency, and other clinical outcomes. The trial focuses on long-term clinical efficacy and safety of the two injection approaches.

Why it matters

Potential benefit: If successful, the MTrP injection could offer similarly effective, simple, and safer-to-deliver long-term pain relief compared with C2 nerve blocks, improving headache control and quality of life.

How similar studies have gone: Previous domestic and international studies have reported that glucocorticoid injections at MTrPs and occipital/dorsal root nerve blocks can relieve cervicogenic headache, but long-term head-to-head non-inferiority comparisons are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with cervicogenic headache by at least two pain specialists or neurologists;
* Disease duration of at least 3 months;
* Age between 18 and 65 years;
* Numerical Rating Scale (NRS) score ≥ 3 despite conservative pharmacological treatment;
* Signed informed consent form.

Exclusion Criteria:

* History of allergy to trial medications such as corticosteroids;
* Alcohol abuse; long-term use of opioids (exceeding 2 weeks or more than 3 days per week for over 1 month); suspected use of sedative or analgesic medications; patients on long-term steroid therapy;
* Severe neurological disorders, significant hepatic or renal dysfunction, heart failure, coagulation abnormalities, gastric ulcer, diabetes, inflammatory rheumatic diseases, etc.;
* Inability to use pain assessment scales;
* Presence of local or systemic infection;
* Pregnant or lactating patients.

Where it's running

  • Beijing Tiantan Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.